title: All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene.
authors.forename: S
authors.initials: S
authors.lastname: Strehl
authors.forename: M
authors.initials: M
authors.lastname: König
authors.forename: H
authors.initials: H
authors.lastname: Boztug
authors.forename: B W
authors.initials: BW
authors.lastname: Cooper
authors.forename: K
authors.initials: K
authors.lastname: Suzukawa
authors.forename: S-J
authors.initials: SJ
authors.lastname: Zhang
authors.forename: H-Y
authors.initials: HY
authors.lastname: Chen
authors.forename: A
authors.initials: A
authors.lastname: Attarbaschi
authors.forename: M N
authors.initials: MN
authors.lastname: Dworzak
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D010087:Oxides / Q000627:therapeutic use*; D018168:Receptors, Retinoic Acid / Q000235:genetics*; D000072482:Retinoic Acid Receptor alpha; D050799:STAT5 Transcription Factor / Q000235:genetics*; D014212:Tretinoin / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D015514:Oncogene Proteins, Fusion; D010087:Oxides; C000607071:RARA protein, human; D018168:Receptors, Retinoic Acid; D000072482:Retinoic Acid Receptor alpha; D050799:STAT5 Transcription Factor; C494095:STAT5B protein, human; D014212:Tretinoin; D000077237:Arsenic Trioxide